Dojolvi OverviewTriheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD). The most common adverse reactions include abdominal pain, diarrhea, vomiting, and nausea. Triheptanoin was approved for medical use in the United States in June 2020. Triheptanoin is a triglyceride...
Read more Dojolvi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Triheptanoin
Recent Dojolvi Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Liquid: 100% W/w, 35%
NDC Database Records for Dojolvi: (1 result)Sorted by National Drug Code
- 69794-050 Dojolvi .96 g/ml Oral Liquid by Ultragenyx Pharmaceutical Inc.